Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future.

ABSTRACT: Intradermal immunization has become a forefront of vaccine improvement, both scientifically and commercially. Newer technologies are being developed to address the need to reduce the dose required for vaccination and to improve the reliability and ease of injection, which have been major hurdles in expanding the number of approved vaccines using this route of administration. In this review, 7 y of clinical experience with a novel intradermal delivery device, the MicronJet600, which is a registered hollow microneedle that simplifies the delivery of liquid vaccines, are summarized. This device has demonstrated both significant dose-sparing and superior immunogenicity in various vaccine categories, as well as in diverse subject populations and age groups. These studies have shown that intrade

SUBMITTER: Levin Y 

PROVIDER: S-EPMC4514308 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature